27 Oct 2015

Ganfort (Bimatoprost / Timolol) - Italia

ATC: S01ED
SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIGLAUCOMA PREPARATIONS AND MIOTICS
BETA BLOCKING AGENTS
Ganfort

Last Updated on 27 Oct 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Ganfort Indication

Riduzione della pressione intraoculare (PIO) in pazienti adulti con glaucoma ad angolo aperto o con ipertensione oculare, che non rispondono adeguatamente ai beta-bloccanti o agli analoghi delle prostaglandine per uso topico.

 

Ganfort Generic Name

Bimatoprost / Timolol

Type

POM

Summary Product Characteristics (SPCs) Links
Riassunto delle Caratteristiche del Prodotto - Ganfort (external site)

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Selected content related to Ganfort (Bimatoprost / Timolol)

Guidelines

Ganfort Marketing Information

Ganfort Generic Name
Bimatoprost / Timolol
Marketing Company
Allergan Pharmaceuticals Ireland
Drug Type
POM
Date of Issue, Marketing Authority

19/05/2006

Related Drugs - Eye Health and Disorders

Back to top